O

OCGN

OCGN

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
30%Bearish
Buy/Sell Ratio5% buys
BearishBullish
OCGN Live QuoteReal-time
$0.73
$0.09(-10.63%)1M
Day Range$0.72 – $0.75
Open$0.74
Previous Close$0.74
Volume9.35M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$248.64M
P/E Ratio (TTM)24.5
Forward P/E13.1
EPS (TTM)$-0.20
Price to Book75.9
Dividend Yield0.65%
Beta (Volatility)1.98
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.73 (2%)
Low: $0.69High: $2.73
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$12.17-91.9% upside

Insider Buys

3

$58K

Insider Sales

2

$1.09M

Total Volume

$1.15M

10 transactions

Net Activity

$1.03M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
55CONFIDENCE

Sentiment Rating

Neutral / Balanced

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 95% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys5 sells

$12.92B total

M
2

Musunuri Shankar

CEO

0 buys2 sells

$1.09M total

J
3

Johnson-Greene Treerita Essalima

CFO

1 buys0 sells

$26K total

C
4

Castillo Kirsten

Dir

1 buys0 sells

$23K total

F
5

Fernandes Prabhavathi

Dir

1 buys0 sells

$9K total

Trading History
OCGN insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 9, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell5.05M$-525991.00$0

Oct 9, 2026

1 months ago

Musunuri Shankar

CEO

CEO
Sell526.0K$0.95$500K

Sep 9, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell5.58M$-525991.00$0

Sep 9, 2026

2 months ago

Musunuri Shankar

CEO

CEO
Sell526.0K$1.12$589K

Jun 15, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell521.4K$21000.00$10.95B

Jun 15, 2026

5 months ago

Johnson-Greene Treerita Essalima

CFO

CFO
Buy21.0K$1.23$26K

Nov 26, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell10.0K$10000.00$100.00M

Nov 26, 2024

24 months ago

Fernandes Prabhavathi

Dir

Director
Buy10.0K$0.91$9K

Nov 22, 2024

24 months ago

Castillo Kirsten

Dir

Director
Buy25.0K$0.91$23K

Nov 22, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell75.0K$25000.00$1.88B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
OCGN Buy Conviction5%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.52B

OCGN has an insider buy conviction of 5%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for OCGN

Over the last 90 days, corporate insiders at OCGN (OCGN) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 2 were sales. The total volume of insider trading reached $1.15M.

The net insider activity for OCGN shows a net selling bias of $1.03M. This activity represents a 5% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 521.4K shares valued at $10.95B on Jun 15, 2026.

Live Market News & Developments
Aggregated real-time headlines for OCGN (OCGN)
6 updates

Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View

Yahoo Finance149d ago

Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?

TradingView170d ago

Ocugen (NasdaqCM:OCGN) Stock Forecast & Analyst Predictions

Simply Wall St9d ago

OCGN - Ocugen Inc Stock Price and Quote

Finviz175d ago

OCGN Stock Slides As Traders Focus On Cash Burn And Key Support

Timothy Sykes72d ago

An officer proposes selling 525,991 Ocugen (OCGN) shares through Merrill Lynch.

Stock Titan42d ago

FAQs About OCGN Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for OCGN.

Based on SEC Form 4 disclosures, the Insider Confidence Score for OCGN is currently 55/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 3 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for OCGN is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.